33
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A Mouse Model of Zika Virus Pathogenesis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Due to the ongoing Zika virus (ZIKV) epidemic and unexpected clinical outcomes including Guillain-Barré syndrome and birth defects, there is an urgent need for animal model development. We evaluated infection and pathogenesis with contemporary and historical ZIKV strains in immunocompetent mice and transgenic mice lacking components of the innate antiviral response. Whereas 4 to 6 week-old wild-type, Irf3 −/−, Irf5 −/−, and Mavs −/−, mice showed no overt clinical illness, Irf3 −/− Irf5 −/− Irf7 −/− TKO and Ifnar1 −/− mice developed neurological disease and succumbed to ZIKV infection. Ifnar1 −/− mice sustained high viral loads in the brain and spinal cord, consistent with evidence that ZIKV causes neurodevelopmental defects in human fetuses. The highest viral loads were detected in the testes of Ifnar1 −/− mice, which is relevant to sexual transmission of ZIKV. This model of ZIKV pathogenesis will be valuable for evaluating vaccines and therapeutics, as well as understanding basic mechanisms of disease pathogenesis and immune evasion.

          Graphical Abstract

          Related collections

          Author and article information

          Journal
          101302316
          33345
          Cell Host Microbe
          Cell Host Microbe
          Cell host & microbe
          1931-3128
          1934-6069
          1 April 2016
          05 April 2016
          11 May 2016
          11 May 2017
          : 19
          : 5
          : 720-730
          Affiliations
          [1 ]Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
          [2 ]Department of Medicine, Washington University School of Medicine, St Louis, MO 63110
          [3 ]Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110
          [4 ]Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO 63110
          [5 ]The Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO 63110
          Author notes
          [* ]Address correspondence to: Michael S. Diamond, M.D. Ph.D., Departments of Medicine, Molecular Microbiology, and Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Ave. Box 8051, Saint Louis, MO 63110, USA. diamond@ 123456borcim.wustl.edu , (314) 362-2842 or
          Article
          PMC4866885 PMC4866885 4866885 nihpa773783
          10.1016/j.chom.2016.03.010
          4866885
          27066744
          b8293f2a-34b0-4cf5-98a3-44826f1f7524
          History
          Categories
          Article

          Comments

          Comment on this article